On April 24, 2024, Cidara Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.04 USD | +0.84% |
|
+6.64% | -24.18% |
05-15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
05-15 | Cidara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.18% | 54.92M | |
+15.82% | 122B | |
+20.35% | 114B | |
+17.90% | 25.71B | |
-25.31% | 19.02B | |
-19.51% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |
- Stock Market
- Equities
- CDTX Stock
- News Cidara Therapeutics, Inc.
- Cidara Therapeutics, Inc. announced that it has received $240 million in funding from RA Capital Management, L.P., Canaan Management, Inc., BVF Partners L.P. and other investors